Factors Which Influence Adherence in Clinical Trials 
Home > Programmes (40) > STIs & HIV Research (17) > Factors Which Influence Adherence in Clinical Trials
 

Project Focus
Adherence

Project Location
Hillbrow, Johannesburg

Duration of Project

3 months, 2003

Project Partners
n/a

Project Donors
DfiD Knowledge Programme, DfiD National Sexual & Reproductive Health Programme

Contact
Dr Jocelyn Moyes

Project Aims /Objectives
To determine hypothetical as well as actual factors which might influence treatment adherence in a population in inner city Johannesburg

Project Activities
The concern when planning an intervention trial is the expected level of adherence to study treatment in the study population. A number of trials of twice daily suppressive therapy for HSV-2 to determine the impact on HIV acquisition/transmission are being conducted by RHRU, this study determined hypothetical as well as actual factors influencing treatment adherence in a population in inner city Johannesburg, the target population of these trials.

Anticipated/Actual Results
36 participants returned their treatment diaries at one month. Ninety three percent of treatment doses were taken. Factors associated with increased adherence to treatment included using an alarm clock as a reminder, identifying a support person to remind the participant about treatment, taking treatment during other routine activities such as brushing their teeth, and using support groups. Barriers to treatment adherence included a change in routine, traveling away from home and myths regarding the effects of treatment. Detailed results of the study are being prepared for publication

Additional Outputs
tba

Future Plans
TBA


 Projects in the STI's & HIV Research Cluster:

  A Multi Center Acute HIV-1 Infection Prospective Observational Cohort Study
  DfiD Research Programme Consortium: Consortium for Research and Capacity Building in Reproductive and Sexual Health and HIV/AIDS in developing countries
  A Safety & Acceptability Study of a Vaginal Ring Microbicide Delivery Method for the Prevention of HIV Infection in Women (IPM011)
  Acute HIV infection (AHI) identification
  Contraceptive Research Planning Survey: Comparison of DEPO-PROVERA and IUD Pilot Study
  A phase III randomized, double blind, placebo controlled trial of acyclovir for the reduction of HIV acquisition among high risk HSV2+ HIV- individuals (HPTN039) (known locally as Thembalethu)
  Sub-study to an international multi-centre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 0.5% and 2% PRO 2000/5 gels for the prevention of vaginally acquired HPV infection
  A multi-centred randomised trial of therapeutic intervention at primary HIV-1 infection (also known as SPARTAC)
  An international multi-centre, randomised, double-blind, placebo-controlled trial to evaluate the efficacy and safety of 0.5% and 2% PRO 2000/5 gels for the prevention of vaginally acquired HIV infection
  National Research Foundation Thuthuka Programme: Developing & Advancing Excellence in Researchers
  The Safety and feasibility study of the diaphragm used with Acidform gel or KY Jelly
  Evaluation of quadrivalent HPV vaccine in reducing the incidence of anogenital warts and related genital infection in young men
  IPM Microbicide Feasibility Study
  STI/HIV Research Adherence
  STI/HIV Research HSV2 Shedding
  STI/HIV Research Gates PIP
  Focus on Men: A Programme to Improve Male Involvement in Sexual & Reproductive Health (known locally as Mpilonhle-Mpilonde)